RevCycleAI← Company Intelligence
Company Intelligence

SmarterDx

Clinical AI platform for hospital revenue integrity, CDI, quality and denials that analyzes 100% of clinical data to identify missed documentation and reimbursement opportunities.
Revenue IntegrityClinical AIPrivate
2020
New York City
Private
Growth / strategic investment

RevCycleAI Brief

Published research

Clinical AI platform for hospital revenue integrity, CDI, quality and denials that analyzes 100% of clinical data to identify missed documentation and reimbursement opportunities.

Clinical AIRevenue integrityClinical documentation analysisClinical documentation integrityPrebill reviewDenials appealsQuality captureClinical note intelligence

✦ Ask RevCycleAI about SmarterDx

Pro AI analyst

Go deeper on competitors, positioning, buyers, funding and market signals.

Unlock Ask RevCycleAI →

Key findings

Research highlights

SmarterDx has unusually strong customer ROI evidence for a clinical AI company. New Mountain backing and the Pieces acquisition make it a credible platform-consolidation candidate rather than merely a CDI point solution.

UAMS reported $5.3M in annual net new revenue from SmarterPrebill

Acquired Pieces Technologies and launched SmarterNotes

New Mountain Capital made a strategic investment to support product innovation and growth

Raised $50M Series B led by Transformation Capital, bringing disclosed funding to $71M

RevCycleAI Intelligence Scores

Methodology
59
70
67
51

Market Matrix: Major Contender · Impact 66 · Capability 61

Funding & transaction history

1 tracked
2024-05-01 · Acquisition · $50M

AI-powered CDI and quality audit platform for medical claims. Acquired by New Mountain Capital and merged into Smarter Technologies alongside Thoughtful AI and Access Healthcare.

Full research

Deep Dive